Notice 1 May 2025 dea, drug enforcement, regulatory compliance, controlled substances, pharmaceutical industry

💊Importer of Controlled Substances Application by US Pharmacopeial Convention

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 1 May 2025 drug enforcement, regulatory compliance, controlled substances, business applications, pharmaceuticals

💊DEA Notice on Importer Application for Controlled Substances

Unither Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 manufacturing, controlled substances, pharmaceutical industry, compliance, dea, drug regulation

💊Bulk Manufacturer Registration Application by Pisgah Laboratories

Pisgah Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, pharmaceutical industry, compliance, clinical trials, drug enforcement

💊Almac Clinical Services' Importer Application for Controlled Substances

Almac Clinical Services, Inc., (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, regulation, compliance, pharmaceuticals, business operations, dea, skalar pharma llc

💊Skalar Pharma LLC's Application for Importing Controlled Substances

Skalar Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, regulatory, business registration, compliance, drug enforcement

⚖️VHG Labs Controlled Substances Import Application Overview

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 healthcare, controlled substances, compliance, pharmaceuticals, regulations, dea

💊Siemens Healthcare Diagnostics Applies for Controlled Substances Registration

Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 controlled substances, import permits, regulatory compliance, business operations, drug enforcement

🚨Lipomed's Application for Importing Controlled Substances Notice

Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 pharmaceutical regulation, controlled substances, drug manufacturing, dea, business compliance

💊DEA Notice on Controlled Substances Application Correction

The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 26, 2025, concerning a notice of application for bulk manufacturer of Controlled Substances. As that document indicated the registrant's incorrect plans for the listed controlled substances.

Learn More
Notice 25 Apr 2025 pharmacy regulations, drug enforcement, controlled substances, business compliance, dea, pennsylvania

💊DEA Revokes Registrations of Multiple Pennsylvania Pharmacies

The DEA issued an Order to Show Cause and Immediate Suspension of Registrations to several pharmacies, alleging violations related to the dispensing and recordkeeping of controlled substances. The findings indicate significant discrepancies in record management, endangering public health, and leading to potential revocation of their registration for the sale of drugs.

Learn More